http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9010000-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-06 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-06 |
filingDate | 1990-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d33700e831b61a217e7f8c46fafc6003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9bddb9a460f78e5cb02d6f627298cce |
publicationDate | 1990-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-9010000-A1 |
titleOfInvention | Cyclic carbamate analogues of (+)-pilocarpine |
abstract | Pilocarpine analogues are provided having the structure (I), where one of R1? or R2? is an alkyl, such as methyl, ethyl, propyl, butyl, and so forth, and the corresponding secondary alkyl groups, an aralkyl, such as benzyl, phenylethyl, phenylpropyl, and the corresponding secondary aralkyl residues, or a cycloalkyl having less than about 12 carbon atoms. R3? has at least two carbon atoms but less than about 9. These pilocarpine analogues have improved duration of biological activity with respect to pilocarpine. A particularly preferred compound is a muscarinic agonist equipotent with pilocarpine, where R2? is methyl, and R3? is ethyl. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2239910-A1 |
priorityDate | 1989-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 129.